Nanoparticles Vaccines Now and Future!
Journal Title: Journal of Vaccines and Immunology - Year 2015, Vol 1, Issue 1
Abstract
While the advanced use of effective vaccines has had an extraordinary impact on global health, there remain many diseases for which vaccines are not available. The concept of therapeutic infection vaccines is based on the activation of the immune system against infection after the presentation of microbes’ antigens to provide long-term protection against an infection. Nanoparticles (The term “nanoparticle” refers to a crystallite or primary particle measuring less than 100 nm in size.) have shown great potential as delivery systems for infection vaccines as they potentiate the co-delivery of microbe-associated antigens and adjuvants to antigens presenting cells, insuring effective activation of the immune system against microbes in order to develop a specific immune response able to protect or to cure infected animals.
Authors and Affiliations
AL-MARIRI Ayman
Keywords
Related Articles
- EP ID EP553515
- DOI 10.17352/jvi.000002
- Views 52
- Downloads 0
Mild Encephalitis/Encephalopathy with a Reversible Splenial Lesion Associated with Rhinovirus Infection
We report a 7-year-old patient with mild encephalopathy with a reversible splenial lesion (MERS) presenting with recurrent delirious behavior, hallucinations and seizures following common cold. Cranial MRI showed high si...
Nanoparticles Vaccines Now and Future!
While the advanced use of effective vaccines has had an extraordinary impact on global health, there remain many diseases for which vaccines are not available. The concept of therapeutic infection vaccines is based on th...
Mammalian Parasitic Vaccine: A Consolidated Exposition
Parasites are highly prevalent in livestock worldwide and infect over one fourth of the human population also. Parasites are successful in evading host immune responses, and vaccination can prove to be an effective way t...
Liposome Adjuvants: Simultaneous Induction of Innate and Adaptive Immunity is Key to Success
The current generation vaccines are mainly composed of highly purified antigens and tend to be poorly immunogenic, requiring potent adjuvants for their success. The adjuvants currently available suffer from various drawb...
IMS 4112 and VLP of HBV as Th1 Adjuvants for a Recombinant Protein of HIV-1
Background: Current thinking suggests that vaccination approaches against the HIV-1 should be directed to elicit a Th1 cell-mediated immunity, neutralizing antibodies and/or ADCC mediating antibody responses. Also, exper...